Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2018

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Tailor-made Pharma Solutions

Make better informed business decisions with customized pharmaceutical consulting and marketing services that give you the edge over your competition.

Tailor-made solutions

Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:

A customized approach – we develop solutions to fit your situation
Joint problem/opportunity definition
Proprietary data and complementary market research
The experience of 500+ industry experts
Collaborative problem solving
Fact-based decisions and actionable recommendations
Ownership of final decisions and action plans

Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.

Biomedtracker

Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets

By Dominique Fontanilla 13 Nov 2018

Understand important upcoming milestones that will impact the likelihood of drug approval or future sales potential for key therapies during a free webinar from Informa Pharma Intelligence, "Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets".

Topic Drug development landscape

Full video
Research and Development Strategy Solutions

Pharma Intelligence Marketing Services: Watch the Video

13 Nov 2018

Marketing Services from Informa Pharma Intelligence connects you to the key decision makers you need to reach. Boasting the most accurate and trusted pharma and medtech intelligence in the industry.

Full video
Citeline, Citeline Analytics

2017 Completed Clinical Trials: Status Quo or No Webinar Recording

By Laura Runkel 08 Nov 2018

For a deeper look into the data behind last year’s completed clinical trials and the trends driving them, Listen to the Completed Clinical Trials 2017: Status Quo or No?

Topic Clinical trials

Full video
Trialtrove

2017 Clinical Trials Roundup The Evolution Continues

By Doro Shin 08 Nov 2018

For a detailed look at the statistics and trends surrounding clinical trials initiated in 2017, we invite you to download 2017 Clinical Trials Roundup: The Evolution Continues. Using a wealth of trial data from Trialtrove, this information-packed white paper provides a detailed analysis of Phase I–III clinical trials that were initiated last year.

Topic Clinical trials

View white paper
Scrip

Mens Health Drug Developments in Prostate Cancer

06 Nov 2018

November is Men’s Health Awareness Month, and Informa Pharma Intelligence is providing essential insights into drug developments for prostate cancer. Download now for free the "Men's Health: Drug Developments in Prostate Cancer Article Pack", brought to you by Scrip and Pink Sheet.

Topic Drug development landscape

View article
Citeline

Depression New Insights Shifting the Treatment Paradigm Whitepaper

By Pippa Nutkins 05 Nov 2018

Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are. This data-packed whitepaper from Informa Pharma Intelligence can now be downloaded – free.

Topic Drug development landscape

View white paper
Medtech Insight

Commissioner Says EU MDR/IVDR Implementation 'On Track,' But Fails To Convince Parliament

By Amanda Maxwell 31 Oct 2018

Elżbieta Bieńkowska, a European Commissioner, is "realistic and confident" when it comes to the implementation of the new EU medtech regulations. She says everything is going to plan. But that is not what members of the European Parliament are hearing.

Topic Medtech

View article
Scrip

Pfizer Well Placed To Lead First Line Advanced RCC Market

By Kevin Grogan 31 Oct 2018

Two successful Phase III studies of Inlyta in combination with two distinct immunotherapies, including its own, Merck KGaA-partnered Bavencio, puts Pfizer in a very strong position in the advanced kidney cancer market.

Topic Cancer

View article
Pink Sheet

Alkermes Depression Drug Faces Tough Questions At US FDA Advisory Committee

By Michael Cipriano 31 Oct 2018

If approved, ALKS 5461 would be first opioid-containing product to carry indication for depression; Alkermes CEO Pops tells Pink Sheet that agency's safety and efficacy concerns are surmountable because "all depression drugs have mixed results."

View article
Medtech Insight

Embrace The Digital Revolution, But On Your Own Terms, John Nosta Says

By David Filmore 31 Oct 2018

Digital health and innovation strategist John Nosta talks about the need for medical technology companies to stay true to their technology roots and not get too attached to the "patient centricity" bandwagon. Also: innovating organically and "failing smart."

View article
Scrip

On Drug Price Increases, Pfizer's Read Expects ‘Business As Normal’ In 2019

By Jessica Merrill 31 Oct 2018

Presiding over his last earnings call as the CEO of Pfizer, Ian Read was pressed about the company's drug pricing strategy for 2019 amid push back from the Trump Administration.

Topic Business strategies

View article
Scrip

Scrip Awards By Numbers 2018 Video

29 Oct 2018

Just how important is it to attend SCRIP Awards 2018? We’ve put together this short video to give you the facts and figures from last year’s awards – can you afford to miss this once-a-year opportunity?

Topic Clinical trials

Full video
Meddevicetracker, Medtech Insight

Neuromodulation Device Market Innovations and Trends Webinar

By David Filmore 29 Oct 2018

Join our presenters as they explore the area of neuromodulation, which is seeing significant growth at a time when other medical device markets are facing declining growth. The team focus on three targeted neuromodulation areas, including: spinal cord stimulation (SCS), deep brain stimulation (DBS) and vagus nerve stimulation (VNS).

Full video
Scrip

A timeline of the Takeda/Shire merger

By Mike Ward 26 Oct 2018

A staple of consumer magazines and tabloid newspapers involves coverage of celebrity relationships – who has been seen together? Who is dating? Will they become a permanent item? And are they going to live happily ever after? Readers can’t seem to get enough of it. Interestingly, while maybe not so racy as the celebrity goings-on, pharma industry watchers are keen to follow company couplings. Talk of mergers and acquisitions, one of the ways that companies can build scale, always attracts attention.

Topic Business strategies Company analysis

View interactive data
Medtech Insight

Drug/Software Combo Pathway Coming Soon To US FDA, Gottlieb Says

By Derrick Gingery 26 Oct 2018

Under a new regulatory platform, drugs could soon be approved with accompanying software applications that could monitor adverse events or patient compliance without a separate pre-market device review.

Topic Digital Health

View article

Latest headlines

Pink Sheet

14 Nov 2018

No Quick End To Brexit Activity Hold At EMA

Link
Medtech Insight

14 Nov 2018

QUOTED. Nov. 14, 2018. Matteo Lai.

Link
Scrip

14 Nov 2018

Alnylam Offering Value-Based Deals In EU For Breakthrough RNAi Drug Onpattro

Link
Scrip

14 Nov 2018

Mersana Back On Track After Speedy Changes To ADC Program

Link
In Vivo

14 Nov 2018

US Drug Pricing Reforms Testing Limits Of Executive Action

Link
Pink Sheet

14 Nov 2018

Bayer Consumer Health Yet To Turn Corner Due To Supply, Innovation Detours

Link
Medtech Insight

14 Nov 2018

INFOGRAPHIC: Q3 Recalls Snapshot: Recalled Devices Slide In Third Quarter; Software A Nagging Issue

Link
Medtech Insight

14 Nov 2018

UK MHRA Response To Brexit Questions Still Leaves Gaps And Uncertainty For Medtech

Link
Scrip

14 Nov 2018

Glenmark Re-Evaluates Complex Generics Basket, Won’t Be Part Of The 'Crowd'

Link
Medtech Insight

13 Nov 2018

QUOTED. Nov. 13, 2018. Avi Fischer.

Link
Medtech Insight

13 Nov 2018

Canada Consults On Licensing Of 3D-Printed Device Implants

Link
Scrip

13 Nov 2018

Editas' EDIT-101 Set To Be First In Vivo CRISPR Gene-Editing Therapy In Clinic

Link
Pink Sheet

13 Nov 2018

Scottish HTA Okays Neuroblastoma Ultra Orphan Qarziba

Link
Scrip

13 Nov 2018

Sobi Taps AstraZeneca's RSV Therapies, Both Current And Future, For US Expansion

Link
Pink Sheet

13 Nov 2018

Merck's View On The Challenges Of Ebola Vaccination In The DRC

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Tailor-made Pharma Solutions

Tailor-made solutions

Pharma Intelligence latest insights

Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets

Pharma Intelligence Marketing Services: Watch the Video

2017 Completed Clinical Trials: Status Quo or No Webinar Recording

2017 Clinical Trials Roundup The Evolution Continues

Mens Health Drug Developments in Prostate Cancer

Depression New Insights Shifting the Treatment Paradigm Whitepaper

Commissioner Says EU MDR/IVDR Implementation 'On Track,' But Fails To Convince Parliament

Pfizer Well Placed To Lead First Line Advanced RCC Market

Alkermes Depression Drug Faces Tough Questions At US FDA Advisory Committee

Embrace The Digital Revolution, But On Your Own Terms, John Nosta Says

On Drug Price Increases, Pfizer's Read Expects ‘Business As Normal’ In 2019

Scrip Awards By Numbers 2018 Video

Neuromodulation Device Market Innovations and Trends Webinar

A timeline of the Takeda/Shire merger

Drug/Software Combo Pathway Coming Soon To US FDA, Gottlieb Says

Latest headlines

No Quick End To Brexit Activity Hold At EMA

QUOTED. Nov. 14, 2018. Matteo Lai.

Alnylam Offering Value-Based Deals In EU For Breakthrough RNAi Drug Onpattro

Mersana Back On Track After Speedy Changes To ADC Program

US Drug Pricing Reforms Testing Limits Of Executive Action

Bayer Consumer Health Yet To Turn Corner Due To Supply, Innovation Detours

INFOGRAPHIC: Q3 Recalls Snapshot: Recalled Devices Slide In Third Quarter; Software A Nagging Issue

UK MHRA Response To Brexit Questions Still Leaves Gaps And Uncertainty For Medtech

Glenmark Re-Evaluates Complex Generics Basket, Won’t Be Part Of The 'Crowd'

QUOTED. Nov. 13, 2018. Avi Fischer.

Canada Consults On Licensing Of 3D-Printed Device Implants

Editas' EDIT-101 Set To Be First In Vivo CRISPR Gene-Editing Therapy In Clinic

Scottish HTA Okays Neuroblastoma Ultra Orphan Qarziba

Sobi Taps AstraZeneca's RSV Therapies, Both Current And Future, For US Expansion

Merck's View On The Challenges Of Ebola Vaccination In The DRC

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store